Fulgent Genetics Q4 Adj $0.04 Beats $(0.12) Estimate, Sales $76.21M Beat $75.39M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.12) by 133.33 percent. This is a 85.71 percent decrease over earnings of $0.28 per share from
Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.12) by 133.33 percent. This is a 85.71 percent decrease over earnings of $0.28 per share from the same period last year. The company reported quarterly sales of $76.21 million which beat the analyst consensus estimate of $75.39 million by 1.09 percent. This is a 8.10 percent increase over sales of $70.50 million the same period last year.